Articles
When nothing else works
Could psychoactive substances like psilocybin, MDMA and ketamine finally crack the code on treatment-resistant depression, anxiety or PTSD?
May 2, 2023 | Madison Magazine
Kathleen Gallagher: How a Madison area non-profit is accelerating demand for psychedelic mushrooms used to treat mental illness
A look at the landscape of psychedelics being used to treat mental health and how Usona Institute to rising to meet the challenge.
August 9, 2022 | Milwaukee Journal Sentinel
Are you ready for the psychedelic revolution?
The psychedelic revolution in mental health treatment is on the way, with FDA approval likely in just a few years.
July 2, 2022 | NPR: To The Best of Our Knowledge
These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry
In the nascent industry of medical psychedelics, drug development is the name of the game.
June 2, 2022 | Business Insider
Psychedelic-assisted psychotherapy shakes off an old stigma
In the 1960s, the US limited research on psychedelics. Now, these once taboo substances are being recognized for their full medical potential.
March 16, 2022 | National Association of Science Writers
Magic Mushrooms May Be the Biggest Advance in Treating Depression Since Prozac
Magic-mushroom therapy is offering some hope for some previously thought 'hopeless' medical cases.
September 22, 2021 | Newsweek
Parting the Clouds
Charles Raison On New Treatments For Depression
January 29, 2021 | The Sun MagazinePress Releases
Usona Identifies Controlled Crystal Engineering Process for Large-Scale Synthesis of Psilocybin Polymorphs
February 7, 2022
Crystallographic Discoveries Bring New Clarity to Pharmaceutical Psilocybin Polymorph Characterization
December 20, 2021
Media Inquiries
MEDIA REQUESTMedia Inquiries
Please contact karen.burkhartzmeyer@usonainstitute.org with the following information:
- Name and organization
- Description of what you would like to cover
- Deadline